export type SignalingType =
  | "Peptide hormone"
  | "Cytokine"
  | "Growth factor"
  | "Neurotransmitter"
  | "Second messenger"
  | "Signaling pathway"
  | "Gasotransmitter"
  | "Hormone"
  | "Metabolite"
  | "Vitamin";

export interface SignalingEntry {
  id: string;
  name: string;
  etymology: string;
  aliases: string[];
  type: SignalingType;
  source?: string;
  receptor?: string;
  function: string;
  mnemonic?: string;
  clinicalRelevance: string[];
  boardsPearls: string[];
  distinguishFrom?: string[];
  pediatrics?: string;
}

export const SIGNALING_MOLECULES: SignalingEntry[] = [
  {
    id: "bnp",
    name: "Brain natriuretic peptide (BNP)",
    etymology: "brain = discovery tissue + natrium = sodium + ouretikos = urine-promoting + peptide = small protein",
    aliases: [
      "brain natriuretic peptide",
      "b-type natriuretic peptide",
      "b type natriuretic peptide",
      "bnp",
      "nt-probnp",
      "nt probnp",
    ],
    type: "Peptide hormone",
    source: "Ventricular cardiomyocytes (released with myocardial stretch)",
    receptor: "Natriuretic peptide receptors (guanylyl cyclase–linked)",
    function:
      "Counter-regulatory hormone to RAAS: promotes natriuresis, diuresis, and vasodilation; reduces preload and afterload.",
    clinicalRelevance: [
      "↑ in heart failure (ventricular volume/pressure overload)",
      "Used to distinguish cardiac vs pulmonary dyspnea",
      "Guanylyl cyclase activation → ↑ cGMP",
    ],
    boardsPearls: [
      "Stretched ventricle releases BNP — not synthesized in the brain despite the name",
      "HF vignette: dyspnea + ↑ BNP/NT-proBNP + pulmonary edema",
      "ANP (atria) vs BNP (ventricles) — both natriuretic peptides",
    ],
    distinguishFrom: [
      "ANP — atrial stretch, not ventricular",
      "Aldosterone — retains Na⁺/water; BNP promotes natriuresis",
      "ADH — water retention; opposite effect on volume",
    ],
    pediatrics:
      "Congenital heart disease with volume overload can elevate BNP; interpret against age-specific norms when available.",
  },
  {
    id: "anp",
    name: "Atrial natriuretic peptide (ANP)",
    etymology: "atrium = heart chamber + natrium = sodium + ouretikos = urine-promoting + peptide = small protein",
    aliases: [
      "atrial natriuretic peptide",
      "anp",
      "atrial natriuretic factor",
      "anf",
    ],
    type: "Peptide hormone",
    source: "Atrial cardiomyocytes (released with atrial stretch/volume overload)",
    receptor: "Natriuretic peptide receptor A (NPR-A; guanylyl cyclase–linked)",
    function:
      "Counter-regulatory to RAAS and ADH: promotes natriuresis, diuresis, and vasodilation; lowers preload and inhibits renin and aldosterone secretion.",
    clinicalRelevance: [
      "↑ with hypervolemia, heart failure, and atrial stretch",
      "Guanylyl cyclase activation → ↑ cGMP → natriuresis",
      "Part of the natriuretic peptide system alongside BNP",
    ],
    boardsPearls: [
      "ANP from atria (stretch) vs BNP from ventricles (stretch)",
      "ANP → ↑ cGMP → natriuresis; opposes RAAS (↓ renin, ↓ aldosterone)",
      "Increased atrial pressure (e.g. mitral regurgitation, HF) → ↑ ANP",
    ],
    distinguishFrom: [
      "BNP — ventricular stretch; more commonly measured in HF workup",
      "Aldosterone — retains Na⁺/water; ANP promotes natriuresis",
      "ADH — water retention; ANP promotes diuresis",
    ],
    pediatrics:
      "Congenital heart disease with atrial volume overload can elevate ANP; neonatal fluid shifts may transiently affect natriuretic peptide levels.",
  },
  {
    id: "vitamin-d",
    name: "Vitamin D (25-hydroxycholecalciferol)",
    etymology: "vitamin = vital amine historical term + chole = bile + calciferol = calcium-carrying sterol",
    aliases: [
      "vitamin d",
      "vitamin d3",
      "cholecalciferol",
      "25-hydroxyvitamin d",
      "25-hydroxycholecalciferol",
      "25 oh vitamin d",
      "25 oh cholecalciferol",
      "calcidiol",
    ],
    type: "Vitamin",
    source:
      "Skin (UV → cholecalciferol/D3) and diet; hepatic 25-hydroxylation yields 25-OH vitamin D (storage form)",
    receptor: "Converted to active 1,25-(OH)₂D → binds intracellular vitamin D receptor (VDR)",
    function:
      "Prohormone for calcitriol: maintains Ca²⁺/phosphate homeostasis via intestinal absorption and bone mineralization after renal 1α-hydroxylation.",
    clinicalRelevance: [
      "Deficiency → rickets (children) / osteomalacia (adults), hypocalcemia, secondary hyperparathyroidism",
      "25-OH vitamin D is the standard lab measurement of vitamin D status",
      "Malabsorption, low sun exposure, CKD, and anticonvulsants increase deficiency risk",
    ],
    boardsPearls: [
      "Vitamin D pathway: D3 (skin/diet) → 25-OH (liver, storage) → 1,25-(OH)₂D (kidney, active)",
      "Measure 25-OH vitamin D for deficiency — not 1,25-(OH)₂D (unless CKD/granulomatous disease)",
      "Deficiency vignette: bone pain, leg bowing, ↑ ALP, low Ca²⁺/phosphate, ↑ PTH",
    ],
    distinguishFrom: [
      "1,25-dihydroxyvitamin D (calcitriol) — active hormone; measured in CKD and granulomatous disease",
      "PTH — raises serum Ca²⁺; vitamin D is upstream nutritional/hormonal partner",
    ],
    pediatrics:
      "Breastfed infants without supplementation at high risk for rickets; vitamin D 400 IU/day recommended; leg bowing and widened growth plates on X-ray.",
  },
  {
    id: "vitamin-k",
    name: "Vitamin K",
    etymology: "vitamin = vital amine historical term + K = Koagulation German spelling",
    aliases: [
      "vitamin k",
      "vitamin k1",
      "vitamin k2",
      "phylloquinone",
      "phytonadione",
      "menaquinone",
    ],
    type: "Vitamin",
    source:
      "K1 (phylloquinone) from leafy greens; K2 (menaquinone) from gut bacteria; stored poorly — requires regular intake",
    receptor:
      "Cofactor for γ-glutamyl carboxylase in hepatocyte ER — enables γ-carboxylation of glutamate residues on clotting factors",
    function:
      "Essential cofactor for hepatic synthesis of active vitamin K–dependent clotting factors (II, VII, IX, X) and anticoagulant proteins C and S.",
    clinicalRelevance: [
      "Deficiency → impaired γ-carboxylation → bleeding with ↑ PT (extrinsic pathway affected first)",
      "Neonatal hemorrhagic disease prevented by vitamin K injection at birth",
      "Warfarin inhibits vitamin K epoxide reductase → functional deficiency of factors II, VII, IX, X",
      "Broad-spectrum antibiotics can cause deficiency by killing gut K2-producing bacteria",
    ],
    boardsPearls: [
      "Vitamin K–dependent factors: 2, 7, 9, 10 and proteins C & S — warfarin mnemonic",
      "Warfarin inhibits vitamin K epoxide reductase — not direct factor destruction",
      "Neonates lack gut flora and breast milk is low in K — prophylactic IM vitamin K at birth",
      "Give vitamin K (phytonadione) to reverse warfarin in serious bleeding",
    ],
    distinguishFrom: [
      "Vitamin C — collagen synthesis, scurvy; not coagulation",
      "Calcium — cofactor in coagulation cascade on phospholipid surfaces, not γ-carboxylation",
      "Heparin — accelerates antithrombin; does not affect vitamin K synthesis",
    ],
    pediatrics:
      "Vitamin K deficiency bleeding (VKDB) in newborns — give IM vitamin K at birth; classic VKDB days 2–7, late VKDB weeks 2–12 in exclusively breastfed infants without prophylaxis.",
  },
  {
    id: "bile-acid",
    name: "Bile Acid",
    etymology: "Latin bilis = bile + acid = sour/proton-donating substance",
    aliases: [
      "bile acid",
      "bile acids",
      "bile salt",
      "bile salts",
      "cholic acid",
      "chenodeoxycholic acid",
      "taurocholate",
      "glycocholate",
    ],
    type: "Metabolite",
    source:
      "Hepatocytes synthesize primary bile acids from cholesterol; conjugated bile salts are secreted into bile and stored/concentrated in gallbladder",
    receptor:
      "Micellar detergent action in intestinal lumen; FXR/TGR5 signaling regulates bile acid and lipid metabolism",
    function:
      "Amphipathic cholesterol-derived molecules that emulsify dietary lipids, form micelles for fat and fat-soluble vitamin absorption, and undergo enterohepatic recirculation with terminal ileal reabsorption.",
    clinicalRelevance: [
      "Ileal disease or resection → bile acid malabsorption, watery diarrhea, fat malabsorption, and gallstone risk",
      "Bile acid sequestrants bind bile acids in gut → ↓ LDL but can worsen hypertriglyceridemia",
      "Cholestasis ↓ bile delivery to intestine → fat-soluble vitamin deficiency and steatorrhea",
      "Bile acids solubilize cholesterol; imbalance promotes cholesterol gallstones",
    ],
    boardsPearls: [
      "Bile acids come from cholesterol — major route for cholesterol elimination",
      "Conjugation with glycine/taurine makes bile salts more water soluble",
      "Terminal ileum reabsorbs bile acids; B12 also absorbed in ileum",
      "Micelles are required for vitamins A, D, E, K absorption",
      "Cholestyramine binds bile acids and interrupts enterohepatic recirculation",
    ],
    distinguishFrom: [
      "Bilirubin — heme breakdown pigment excreted in bile, not lipid detergent",
      "Pancreatic lipase — enzyme that digests triglycerides after bile emulsification",
      "Cholesterol — precursor and gallstone component, not itself a bile acid",
    ],
    pediatrics:
      "Biliary atresia or neonatal cholestasis can impair bile acid delivery, causing pale stools, conjugated hyperbilirubinemia, steatorrhea, and fat-soluble vitamin deficiency.",
  },
  {
    id: "active-vitamin-d",
    name: "1,25-Dihydroxycholecalciferol (calcitriol)",
    etymology: "di- = two + hydroxy = OH group + chole = bile + calci- = calcium + -triol = three alcohol groups",
    aliases: [
      "1,25-dihydroxycholecalciferol",
      "1,25-dihydroxyvitamin d",
      "1,25 dihydroxycholecalciferol",
      "1,25 dihydroxyvitamin d",
      "calcitriol",
      "active vitamin d",
    ],
    type: "Hormone",
    source: "Renal proximal tubule (1α-hydroxylation of 25-OH vitamin D)",
    receptor: "Intracellular vitamin D receptor (VDR) → nuclear transcription",
    function:
      "↑ intestinal Ca²⁺ and phosphate absorption; with PTH, mobilizes bone mineral; feedback inhibits PTH secretion.",
    clinicalRelevance: [
      "Chronic kidney disease → ↓ 1α-hydroxylase → secondary hyperparathyroidism",
      "Vitamin D deficiency → rickets/osteomalacia",
      "Hypercalcemia with granulomatous disease (macrophage 1α-hydroxylase)",
    ],
    boardsPearls: [
      "PTH ↑ → renal 1α-hydroxylase → ↑ calcitriol (unless CKD)",
      "25-OH vitamin D = storage form; 1,25-(OH)₂D = active hormone",
      "Sarcoidosis/histoplasmosis: extrarenal 1α-hydroxylase → hypercalcemia",
    ],
    distinguishFrom: [
      "25-hydroxyvitamin D — storage/measurement form, not active hormone",
      "PTH — raises serum Ca²⁺; calcitriol is downstream effector",
    ],
    pediatrics:
      "Rickets from vitamin D deficiency or CKD — leg bowing, widened growth plates; calcitriol replacement in renal osteodystrophy.",
  },
  {
    id: "gaba",
    name: "Gamma-aminobutyric acid (GABA)",
    etymology: "gamma = third carbon position + amino = nitrogen group + butyric = butter acid + acid = proton donor",
    aliases: [
      "gamma-aminobutyric acid",
      "gamma aminobutyric acid",
      "gaba",
    ],
    type: "Neurotransmitter",
    source: "GABAergic interneurons (synthesized from glutamate via GAD)",
    receptor: "GABA-A (Cl⁻ channel) and GABA-B (Gi-coupled)",
    function:
      "Primary inhibitory neurotransmitter in the CNS; hyperpolarizes postsynaptic neurons via Cl⁻ influx (GABA-A).",
    clinicalRelevance: [
      "Benzodiazepines and barbiturates potentiate GABA-A",
      "↓ GABAergic tone in anxiety and epilepsy",
      "GABA cannot cross BBB — peripheral GABA supplements ineffective for CNS",
    ],
    boardsPearls: [
      "Benzo + barbiturate MOA: enhance GABA-A → ↑ Cl⁻ conductance",
      "Alcohol withdrawal: ↓ GABA / ↑ glutamate → seizures, DTs",
      "Vigabatrin inhibits GABA breakdown; tiagabine blocks GABA reuptake",
    ],
    distinguishFrom: [
      "Glutamate — primary excitatory neurotransmitter",
      "Glycine — inhibitory, especially in spinal cord",
    ],
    pediatrics:
      "Neonatal seizures may involve GABAergic immaturity; phenobarbital enhances GABA-A in neonatal epilepsy.",
  },
  {
    id: "cytokine",
    name: "Cytokine",
    etymology: "Greek kytos = cell + kinein = move; cell-moving signal",
    aliases: ["cytokine", "cytokines"],
    type: "Cytokine",
    source:
      "Secreted by immune and stromal cells — macrophages, dendritic cells, T and B lymphocytes, endothelial cells, fibroblasts, mast cells",
    receptor:
      "Cytokine receptors (often JAK-STAT pathway); TNF-family receptors activate NF-κB; chemokine receptors (GPCRs) guide leukocyte migration",
    function:
      "Short-range or paracrine signaling proteins coordinating innate and adaptive immunity, inflammation, hematopoiesis, and tissue repair. Major families: interleukins (IL-), interferons (IFN-), tumor necrosis factor (TNF), and chemokines.",
    clinicalRelevance: [
      "Pro-inflammatory cytokines (IL-1, IL-6, TNF-α) drive fever, sepsis, and acute-phase response",
      "Cytokine storm / cytokine release syndrome — excessive systemic cytokines (sepsis, CAR-T therapy, COVID-19, HLH)",
      "Anti-TNF biologics (infliximab, adalimumab, etanercept) — RA, IBD, psoriasis",
      "IL-1 blockade (anakinra) — autoinflammatory syndromes; IL-6 inhibitors (tocilizumab) — cytokine storm, RA",
      "Corticosteroids broadly suppress cytokine gene transcription",
    ],
    boardsPearls: [
      "Interleukins — between leukocytes; interferons — antiviral/immunomodulatory; TNF — inflammation and cachexia; chemokines — chemotaxis",
      "Endogenous pyrogens: IL-1, IL-6, TNF-α → PGE₂ in hypothalamus → fever",
      "Th1 cytokines: IFN-γ, IL-12 (intracellular pathogens); Th2: IL-4, IL-5, IL-13 (allergy, helminths)",
      "JAK-STAT is the dominant cytokine signaling pathway — many biologics target cytokines or their receptors",
      "vs chemokine — cytokine is broader; chemokines specifically direct leukocyte trafficking (e.g., IL-8/CXCL8)",
    ],
    distinguishFrom: [
      "Hormone — typically endocrine, distant targets, classic glands (insulin, cortisol); overlap exists (e.g., IL-6 as hepatic acute-phase signal)",
      "Growth factor — PDGF, EGF, VEGF; emphasize mitogenesis/repair; categories overlap (TGF-β is both)",
      "Complement proteins — cascade opsonization/lysis, not cytokine signaling mediators",
      "JAK-STAT pathway — intracellular signaling cascade downstream of many cytokine receptors",
    ],
    pediatrics:
      "Hemophagocytic lymphohistiocytosis (HLH) — uncontrolled macrophage activation and cytokine storm in children; MIS-C post-COVID also cytokine-driven.",
  },
  {
    id: "jak-stat",
    name: "JAK-STAT Pathway",
    etymology: "JAK = Janus kinase + STAT = signal transducer and activator of transcription",
    aliases: [
      "jak-stat",
      "jak stat",
      "jakstat",
      "jak/stat",
      "jak-stat pathway",
      "jak stat pathway",
      "jak-stat signaling",
      "jak stat signaling",
      "janus kinase stat pathway",
      "janus kinase-stat pathway",
    ],
    type: "Signaling pathway",
    source:
      "Activated by cytokine and some hormone/growth factor receptors lacking intrinsic kinase activity — ligand binding induces receptor dimerization/oligomerization and brings receptor-associated JAK kinases into proximity",
    receptor:
      "Type I/II cytokine receptors and related receptors with cytoplasmic JAKs (JAK1, JAK2, JAK3, TYK2); common γ-chain cytokine receptors use JAK3",
    function:
      "Canonical cascade: ligand → receptor-JAK activation → JAK transphosphorylation → STAT recruitment and phosphorylation → STAT dimerization → nuclear translocation → transcription of cytokine-responsive genes (immune activation, proliferation, acute-phase response, hematopoiesis).",
    clinicalRelevance: [
      "Dominant downstream pathway for many interleukins, interferons, erythropoietin, prolactin, and growth hormone",
      "JAK inhibitors (tofacitinib, baricitinib, upadacitinib) — rheumatoid arthritis, psoriatic arthritis, IBD; block STAT phosphorylation",
      "Ruxolitinib (JAK1/JAK2 inhibitor) — myelofibrosis and polycythemia vera with JAK2 V617F",
      "JAK2 V617F activating mutation — polycythemia vera, essential thrombocythemia, primary myelofibrosis (MPNs)",
      "STAT3 loss-of-function — autosomal dominant hyper-IgE syndrome (Job syndrome)",
      "JAK3 deficiency — X-linked severe combined immunodeficiency (common γ-chain cytokine signaling failure)",
    ],
    boardsPearls: [
      "Steps: cytokine binds → JAK activation → STAT phosphorylation → STAT dimer → nucleus → gene transcription",
      "IL-6 → JAK → STAT3 (acute-phase proteins, fever); IL-4 → STAT6 (Th2, IgE); IFN-γ → STAT1 (Th1, macrophage activation); EPO → JAK2 → STAT5 (erythropoiesis)",
      "JAK2 V617F = classic MPN driver — think PV when polycythemia + low EPO + JAK2 mutation",
      "Hyper-IgE syndrome: STAT3 mutation → ↑ IgE, eczema, recurrent staph abscesses, retained primary teeth",
      "JAK3 on common γ-chain — IL-2/IL-4/IL-7/IL-9/IL-15/IL-21 receptors; JAK3 defect = X-linked SCID",
      "vs NF-κB — TNF receptor pathway; vs MAPK — many growth factor RTKs; vs cAMP — GPCR second messenger",
    ],
    distinguishFrom: [
      "NF-κB pathway — TNF-family receptors, IκB degradation; overlaps in inflammation but distinct kinases",
      "MAPK/ERK pathway — many receptor tyrosine kinases and growth factors; Ras-Raf-MEK-ERK cascade",
      "cAMP/PKA pathway — GPCR–adenylyl cyclase second messenger (β-adrenergic, glucagon, PTH)",
      "Smad/TGF-β pathway — serine/threonine receptor kinases phosphorylate Smad transcription factors",
      "PI3K/Akt pathway — often parallel to MAPK from RTKs; cell survival and metabolism",
    ],
    pediatrics:
      "X-linked SCID from JAK3 or common γ-chain defects abolishes multiple cytokine JAK-STAT signals. Hyper-IgE (STAT3) presents in childhood with eczema and staph abscesses. JAK inhibitors used cautiously in pediatric autoimmune disease; ruxolitinib in pediatric MPNs per specialist guidance.",
  },
  {
    id: "nf-kb",
    name: "NF-κB (Nuclear Factor Kappa B)",
    etymology: "NF = nuclear factor + Greek kappa = letter K + B = B-cell enhancer binding",
    aliases: [
      "nf-kb",
      "nf kb",
      "nfκb",
      "nf-κb",
      "nf κb",
      "nuclear factor kappa b",
      "nuclear factor kappa-b",
      "nuclear factor-kappa b",
      "nuclear factor-kappa-b",
      "nuclear factor κb",
      "rel/nfkappa b",
      "rel/nuclear factor kappa b",
    ],
    type: "Signaling pathway",
    source:
      "Activated downstream of innate PRRs (TLRs via MyD88/TRIF), pro-inflammatory cytokine receptors (TNF-R, IL-1R), CD40, some antigen receptors, and cellular stress — convergent hub for inflammatory gene transcription",
    receptor:
      "Multiple upstream pathways: TLRs → MyD88/IRAK4/TRAF6 or TRIF; TNF-R1 → TRADD/RIP/TRAF2; IL-1R → MyD88; BCR/TCR co-stimulation and CD40 in lymphocytes; IKK complex (IKKα, IKKβ, NEMO/IKKγ) phosphorylates IκB",
    function:
      "Master pro-inflammatory transcription factor. Resting NF-κB (classically p50/p65 RelA heterodimer) is sequestered in the cytoplasm bound to IκB inhibitor. Stimulus → IKK activation → IκB phosphorylation and proteasomal degradation → NF-κB translocates to nucleus → transcription of cytokines (TNF, IL-1, IL-6), chemokines, adhesion molecules (ICAM, VCAM, E-selectin), COX-2, iNOS, and survival genes.",
    clinicalRelevance: [
      "Central to endotoxic shock — LPS → TLR4 → NF-κB → cytokine storm (TNF-α, IL-1, IL-6)",
      "Drives chronic inflammation in RA, IBD, and psoriasis — upstream of many anti-TNF/IL-1/IL-6 targets",
      "Constitutive NF-κB activation in some lymphomas (e.g., MALT lymphoma with BCL10/MALT1/CARD11 mutations)",
      "Proteasome inhibitors (bortezomib) block IκB degradation step — used in multiple myeloma",
      "Aspirin (high dose) and some NSAIDs can inhibit NF-κB via IKKβ",
      "Mutations in NF-κB pathway components cause combined immunodeficiency or autoinflammation (e.g., NEMO/IKKγ, IκBα)",
    ],
    boardsPearls: [
      "Resting: NF-κB + IκB in cytoplasm → stimulus → IKK → IκB degraded → NF-κB to nucleus",
      "LPS/TLR4 and TNF-α/TNF-R1 both converge on NF-κB — links innate and inflammatory cytokine signaling",
      "MyD88 → IRAK4 → TRAF6 → TAK1 → IKK → NF-κB (shared with IL-1R; defective in MyD88/IRAK-4 deficiency)",
      "vs JAK-STAT — cytokine JAK phosphorylation of STATs; NF-κB uses IκB degradation, not STAT",
      "vs MAPK — parallel downstream of many receptors; distinct kinase cascade (Ras-Raf-MEK-ERK)",
      "Proteasome inhibition traps NF-κB in cytoplasm by preventing IκB degradation",
      "Rel/NF-κB family: p65 (RelA), c-Rel, RelB, p50, p52 — heterodimers bind κB DNA motifs",
    ],
    distinguishFrom: [
      "JAK-STAT pathway — STAT phosphorylation and dimerization; dominant for many interleukins and interferons",
      "MAPK/ERK pathway — growth factor and stress kinase cascade; overlaps upstream but different transcription factors",
      "NLRP3 inflammasome — caspase-1 and IL-1β maturation; can be activated by DAMPs downstream of but distinct from NF-κB",
      "IRF3 — type I interferon transcription factor from TRIF/TBK1 arm of TLR3/TLR4, not NF-κB",
      "AP-1 (Fos/Jun) — often co-activated with NF-κB via MAPK but separate transcription factor",
    ],
    pediatrics:
      "NEMO (IKKγ) deficiency — X-linked combined immunodeficiency with ectodermal dysplasia and susceptibility to pyogenic and mycobacterial infection. MyD88/IRAK-4 deficiency impairs TLR/IL-1R→NF-κB signaling → recurrent bacterial infections in infancy without severe viral susceptibility. Neonatal gram-negative sepsis — excessive NF-κB-driven cytokine release.",
  },
  {
    id: "il-1",
    name: "Interleukin-1 (IL-1)",
    etymology: "Latin inter = between + Greek leukos = white cell + 1 = first numbered subtype",
    aliases: [
      "interleukin-1",
      "interleukin 1",
      "il-1",
      "il 1",
      "il-1α",
      "il-1β",
      "il-1 alpha",
      "il-1 beta",
    ],
    type: "Cytokine",
    source:
      "Activated macrophages, monocytes, dendritic cells, endothelial cells, and many other cell types (IL-1β is the predominant secreted form)",
    receptor:
      "IL-1 receptor type I (IL-1RI) → MyD88 → NF-κB and MAPK; naturally antagonized by IL-1 receptor antagonist (IL-1Ra)",
    function:
      "Potent pro-inflammatory cytokine and endogenous pyrogen: induces fever (hypothalamic PGE₂), activates endothelium (↑ adhesion molecules), stimulates acute-phase response, and promotes leukocyte recruitment and tissue catabolism.",
    mnemonic:
      "IL-1 = first alarm: fever + endothelium wakes up first in acute inflammation.",
    clinicalRelevance: [
      "Endogenous pyrogen with IL-6 and TNF-α → fever in infection and inflammation",
      "Central to autoinflammatory disease — unregulated IL-1 signaling (e.g., NLRP3 inflammasome → ↑ IL-1β)",
      "Anakinra (recombinant IL-1Ra) — CAPS, gout flares, RA; canakinumab (anti–IL-1β) — autoinflammatory syndromes",
      "Septic shock and SIRS — IL-1 contributes to cytokine cascade with TNF and IL-6",
      "Bone resorption in inflammatory arthritis — IL-1 stimulates osteoclast activity",
    ],
    boardsPearls: [
      "IL-1, IL-6, TNF-α — classic endogenous pyrogen triad → PGE₂ in hypothalamus → fever",
      "IL-1β released via inflammasome (NLRP3) — gout crystals, CAPS, periodic fever syndromes",
      "Anakinra = IL-1 receptor antagonist (blocks IL-1α and IL-1β)",
      "IL-1 drives acute inflammation and endothelial activation; less hepatocyte-specific than IL-6",
      "Corticosteroids ↓ IL-1 transcription among many cytokines",
    ],
    distinguishFrom: [
      "IL-6 — primarily drives hepatic acute-phase proteins (CRP, fibrinogen) via STAT3; tocilizumab target",
      "TNF-α — granuloma formation, anti-TNF indications in IBD/RA/psoriasis; overlaps in fever and inflammation",
      "IL-2 — T-cell growth factor, not primary pyrogen or acute-phase driver",
      "Prostaglandin E₂ — downstream mediator of fever, not the upstream cytokine",
    ],
    pediatrics:
      "Periodic fever syndromes (CAPS, FMF) often IL-1–driven — anakinra/canakinumab used in pediatric autoinflammatory disease. Neonatal-onset multisystem inflammatory disease (NOMID/CINCA) responds to IL-1 blockade.",
  },
  {
    id: "il-2",
    name: "Interleukin-2 (IL-2)",
    etymology: "Latin inter = between + Greek leukos = white cell + 2 = second numbered subtype",
    aliases: [
      "interleukin-2",
      "interleukin 2",
      "il-2",
      "il 2",
    ],
    type: "Cytokine",
    source: "Activated CD4⁺ T helper cells",
    receptor: "IL-2 receptor (high-affinity on activated T cells)",
    function:
      "T-cell growth factor: drives clonal expansion and survival of antigen-activated T cells; supports regulatory and effector T-cell populations.",
    mnemonic:
      "IL-2 = T cells make copies of two: activated T cell → more T cells.",
    clinicalRelevance: [
      "Aldesleukin (recombinant IL-2) for metastatic melanoma and renal cell carcinoma",
      "IL-2 signaling blockade (basiliximab) prevents transplant rejection",
      "Capillary leak syndrome with high-dose IL-2 therapy",
    ],
    boardsPearls: [
      "IL-2 = T-cell proliferation signal after antigen activation",
      "Basiliximab: anti-CD25 (IL-2 receptor α chain) for transplant induction",
      "High-dose IL-2 toxicity: capillary leak, hypotension, pulmonary edema",
    ],
    distinguishFrom: [
      "IL-1 — fever, acute inflammation; not primary T-cell growth factor",
      "IL-6 — acute-phase response, B-cell stimulation",
      "Interferon-γ — macrophage activation, TH1 response",
    ],
    pediatrics:
      "SCID from IL-2 receptor γ-chain defects (X-linked SCID); basiliximab used cautiously in pediatric transplant.",
  },
  {
    id: "il-4",
    name: "Interleukin-4 (IL-4)",
    etymology: "Latin inter = between + Greek leukos = white cell + 4 = fourth numbered subtype",
    aliases: [
      "interleukin-4",
      "interleukin 4",
      "il-4",
      "il 4",
    ],
    type: "Cytokine",
    source: "Th2 CD4⁺ T helper cells, mast cells, basophils, NKT cells",
    receptor: "IL-4 receptor (type I and type II; signals via JAK-STAT6)",
    function:
      "Key Th2 cytokine driving B-cell class switching to IgE and IgG4, promoting B-cell proliferation, and suppressing Th1 (macrophage-activating) responses.",
    mnemonic:
      "IL-4 = FOR allergy: Th2 → IgE class switch, unlike IL-5 eosinophils.",
    clinicalRelevance: [
      "Central to allergic/atopic disease — ↑ IL-4 → ↑ IgE → mast cell sensitization",
      "Helminth defense — coordinates eosinophil and IgE-mediated parasite clearance",
      "Dupilumab blocks IL-4 receptor α (shared with IL-13) — atopic dermatitis, asthma",
      "Excess Th2/IL-4 skew in atopy; Th1/IFN-γ skew needed for intracellular pathogen control",
    ],
    boardsPearls: [
      "IL-4 → class switch to IgE (allergy) and IgG4; IL-5 → eosinophils; IL-13 similar to IL-4",
      "Th1 (IFN-γ) vs Th2 (IL-4, IL-5, IL-13) — classic boards paradigm",
      "IL-4 inhibits macrophage activation — opposes IFN-γ from Th1 cells",
      "Mast cells and basophils both produce IL-4, amplifying Th2 responses",
    ],
    distinguishFrom: [
      "IL-2 — T-cell proliferation, not IgE class switching",
      "IFN-γ — Th1 cytokine; activates macrophages for intracellular killing",
      "IL-5 — eosinophil growth and activation, not primary IgE switch factor",
    ],
    pediatrics:
      "Atopic march in children — eczema, food allergy, asthma linked to Th2/IL-4 skew; early allergen sensitization drives IgE production.",
  },
  {
    id: "il-6",
    name: "Interleukin-6 (IL-6)",
    etymology: "Latin inter = between + Greek leukos = white cell + 6 = sixth numbered subtype",
    aliases: [
      "interleukin-6",
      "interleukin 6",
      "il-6",
      "il 6",
    ],
    type: "Cytokine",
    source:
      "Activated macrophages, T cells, B cells, endothelial cells, fibroblasts, and adipocytes",
    receptor:
      "IL-6 receptor (membrane-bound or soluble) + gp130 → JAK → STAT3 (classic pathway); also trans-signaling via soluble IL-6R",
    function:
      "Pro-inflammatory cytokine and endogenous pyrogen that drives the hepatic acute-phase response (↑ CRP, fibrinogen, hepcidin), supports B-cell differentiation and antibody production, and with TGF-β promotes Th17 differentiation.",
    mnemonic:
      "IL-6 = six to the liver: CRP, fibrinogen, hepcidin; acute-phase response.",
    clinicalRelevance: [
      "↑ CRP in infection/inflammation — IL-6 is the main hepatocyte stimulus for acute-phase protein synthesis",
      "Tocilizumab (anti–IL-6R) and siltuximab (anti–IL-6) — RA, cytokine release syndrome, Castleman disease",
      "Endogenous pyrogen with IL-1 and TNF-α → hypothalamic PGE₂ → fever",
      "Elevated in sepsis, cytokine storm, and MIS-C (post–COVID-19 pediatric hyperinflammation)",
      "Contributes to anemia of chronic disease via hepcidin induction",
      "STAT3 loss-of-function mutations → hyper-IgE syndrome (Job syndrome)",
    ],
    boardsPearls: [
      "IL-6 → liver → ↑ CRP and fibrinogen — link IL-6 elevation to acute-phase reactants on boards",
      "IL-1, IL-6, TNF-α — endogenous pyrogen triad",
      "TGF-β + IL-6 → Th17 (RORγt); IL-6 also opposes Treg differentiation in inflammatory settings",
      "Tocilizumab blocks IL-6 receptor — used in RA and severe cytokine release syndrome",
      "IL-6 vs IL-1 — both pyrogenic; IL-6 more specific for hepatic acute-phase response",
      "Hyper-IgE syndrome — STAT3 defect impairs IL-6/IL-10 signaling → impaired Th17 and ↑ IgE",
    ],
    distinguishFrom: [
      "IL-1 — more endothelial/leukocyte activation; anakinra target; inflammasome-driven IL-1β in autoinflammatory disease",
      "TNF-α — granuloma formation, anti-TNF biologics for IBD/psoriasis; NF-κB upstream of IL-6",
      "CRP — downstream acute-phase protein, not the cytokine itself",
      "IL-4 — Th2/IgE axis, not acute-phase or pyrogenic driver",
    ],
    pediatrics:
      "MIS-C after COVID-19 — marked IL-6 elevation treated with IVIG and sometimes tocilizumab. Hyper-IgE (Job) syndrome presents in childhood with eczema, retained primary teeth, and staph abscesses from STAT3/IL-6 pathway defects.",
  },
  {
    id: "il-5",
    name: "Interleukin-5 (IL-5)",
    etymology: "Latin inter = between + Greek leukos = white cell + 5 = fifth numbered subtype",
    aliases: [
      "interleukin-5",
      "interleukin 5",
      "il-5",
      "il 5",
      "eosinophil differentiation factor",
      "edf",
    ],
    type: "Cytokine",
    source: "Th2 CD4⁺ T helper cells, mast cells, and eosinophils",
    receptor: "IL-5 receptor α (CD125) + common β chain (CD131) → JAK-STAT",
    function:
      "Th2 cytokine that promotes eosinophil growth, differentiation, recruitment, activation, and survival; also supports B-cell differentiation and IgA production.",
    mnemonic:
      "IL-5 = fivE for Eosinophils; allergy/helminths need eosinophil help.",
    clinicalRelevance: [
      "Helminth defense — eosinophils kill antibody-coated parasites via major basic protein",
      "Allergic asthma and eosinophilic esophagitis — type 2 inflammation with IL-5-driven eosinophilia",
      "Anti–IL-5 biologics (mepolizumab, reslizumab) and anti–IL-5R (benralizumab) treat severe eosinophilic asthma",
      "Hypereosinophilic syndromes can involve excessive IL-5 signaling",
    ],
    boardsPearls: [
      "IL-5 is the eosinophil cytokine; IL-4 is IgE class switching; IL-13 is mucus/airway hyperreactivity",
      "Th2 triad: IL-4, IL-5, IL-13 — IgE, eosinophils, mucus",
      "Eosinophils contain major basic protein toxic to helminths and epithelium",
      "Asthma with eosinophilia can be treated by blocking IL-5 or IL-5 receptor",
    ],
    distinguishFrom: [
      "IL-4 — B-cell class switch to IgE and Th2 differentiation",
      "IL-13 — mucus production, airway hyperreactivity, and fibrosis",
      "GM-CSF — broader granulocyte/macrophage progenitor growth, not eosinophil-focused",
      "Eotaxin (CCL11) — eosinophil chemotaxis chemokine; IL-5 keeps eosinophils alive/activated",
    ],
    pediatrics:
      "Pediatric atopic asthma can show IL-5-driven eosinophilia; helminth infection remains high-yield for eosinophilia in children with travel or exposure history.",
  },
  {
    id: "il-7",
    name: "Interleukin-7 (IL-7)",
    etymology: "Latin inter = between + Greek leukos = white cell + 7 = seventh numbered subtype",
    aliases: ["interleukin-7", "interleukin 7", "il-7", "il 7"],
    type: "Cytokine",
    source: "Bone marrow and thymic stromal cells; epithelial and fibroblastic stromal cells",
    receptor: "IL-7 receptor α (CD127) + common γ chain (CD132) → JAK1/JAK3-STAT5",
    function:
      "Lymphoid survival and development cytokine: supports early T-cell development, naïve/memory T-cell homeostasis, and early B-cell development in marrow.",
    mnemonic:
      "IL-7 = heaven for lymphocytes: keeps developing T cells alive.",
    clinicalRelevance: [
      "IL7R or common γ-chain defects impair T-cell development and can cause SCID phenotypes",
      "HIV and chemotherapy lymphopenia research often tracks IL-7/T-cell recovery",
      "Common γ chain shared with IL-2, IL-4, IL-7, IL-9, IL-15, IL-21 — X-linked SCID when defective",
    ],
    boardsPearls: [
      "IL-7 is the T-cell development/homeostasis cytokine",
      "Common γ-chain failure → absent T/NK cells with dysfunctional B-cell immunity",
      "Contrast IL-2: activated mature T-cell proliferation; IL-7: lymphoid development/survival",
    ],
    distinguishFrom: [
      "IL-2 — clonal expansion after antigen activation",
      "IL-15 — NK-cell and memory CD8 T-cell survival",
      "IL-3 — early myeloid hematopoietic progenitor growth",
    ],
    pediatrics:
      "Infants with SCID present with severe recurrent infections, chronic diarrhea, thrush, and failure to thrive; IL7R/common γ-chain defects are classic cytokine signaling causes.",
  },
  {
    id: "il-8",
    name: "Interleukin-8 (IL-8 / CXCL8)",
    etymology: "Latin inter = between + Greek leukos = white cell + 8 = eighth numbered subtype; CXCL8 = C-X-C chemokine ligand 8",
    aliases: [
      "interleukin-8",
      "interleukin 8",
      "il-8",
      "il 8",
      "cxcl8",
      "c-x-c motif chemokine ligand 8",
      "neutrophil chemotactic factor",
    ],
    type: "Cytokine",
    source:
      "Macrophages, epithelial cells, endothelial cells, airway smooth muscle cells, and other TLR-activated cells",
    receptor: "CXCR1 and CXCR2 chemokine receptors (GPCRs) on neutrophils",
    function:
      "Chemokine that recruits and activates neutrophils at sites of acute inflammation; promotes neutrophil chemotaxis, degranulation, respiratory burst, and angiogenesis.",
    mnemonic:
      "IL-8 = innate 'ate' call: neutrophils eat bacteria after following CXCL8.",
    clinicalRelevance: [
      "Acute bacterial infection and abscesses — neutrophil recruitment via IL-8/CXCL8, C5a, LTB₄, and fMLP",
      "ARDS, COPD, and severe pneumonia involve IL-8-driven neutrophilic inflammation",
      "Leukocyte adhesion defects impair neutrophil tissue entry downstream of chemotactic signals",
    ],
    boardsPearls: [
      "IL-8/CXCL8 is the classic neutrophil chemotaxis cytokine",
      "Major neutrophil chemoattractants: IL-8, C5a, LTB₄, fMLP",
      "IL-17 induces epithelial/stromal IL-8 and G-CSF → neutrophil recruitment",
      "IL-8 is a chemokine (CXCL8), but still historically named an interleukin",
    ],
    distinguishFrom: [
      "IL-17 — upstream Th17 cytokine that induces IL-8/G-CSF production",
      "C5a — complement-derived chemoattractant and anaphylatoxin",
      "IL-5 — eosinophil growth/activation, not neutrophil chemotaxis",
    ],
    pediatrics:
      "Neonatal neutrophil chemotaxis is relatively immature, contributing to infection susceptibility; leukocyte adhesion deficiency presents in infancy with delayed umbilical cord separation and absent pus despite chemotactic cytokines.",
  },
  {
    id: "tnf",
    name: "Tumor necrosis factor (TNF)",
    etymology: "Latin tumere = swell + Greek nekros = dead + factor = causal agent",
    aliases: [
      "tumor necrosis factor",
      "tumor necrosis factor-alpha",
      "tumor necrosis factor alpha",
      "tnf",
      "tnf-alpha",
      "tnf alpha",
      "tnf-α",
      "tnf α",
      "tnfα",
    ],
    type: "Cytokine",
    source:
      "Activated macrophages, monocytes, dendritic cells, T cells, NK cells, and mast cells",
    receptor:
      "TNF receptors (TNFR1/p55, TNFR2/p75) → NF-κB, JNK, and caspase-mediated apoptosis pathways",
    function:
      "Potent pro-inflammatory cytokine: activates endothelium (↑ adhesion molecules), recruits leukocytes, induces fever, supports granuloma formation, and can cause cachexia and septic shock at high systemic levels.",
    clinicalRelevance: [
      "Endogenous pyrogen with IL-1 and IL-6 → hypothalamic PGE₂ → fever",
      "Central driver of RA, psoriasis, and IBD pathogenesis — target of anti-TNF biologics (infliximab, adalimumab, etanercept)",
      "Anti-drug antibodies (ADAs) to biologics can neutralize anti-TNF drugs → secondary loss of response",
      "Septic shock — excessive TNF and other cytokines → vasodilation, capillary leak, DIC",
      "Latent TB reactivation with anti-TNF therapy — screen before starting",
      "↑ adipose TNF-α contributes to insulin resistance in obesity",
    ],
    boardsPearls: [
      "TNF-α → NF-κB activation → ↑ IL-1, IL-6, adhesion molecules, and other pro-inflammatory mediators",
      "Anti-TNF drugs: infliximab/adalimumab (mAbs), etanercept (decoy receptor) — treat before TB, avoid live vaccines",
      "Endogenous pyrogens: IL-1, IL-6, TNF-α — classic fever triad",
      "Named for tumor necrosis in mice; in humans drives inflammation more than direct tumor killing",
      "TNF vs IL-1 — both acute-phase drivers; TNF more central to granuloma formation and anti-TNF autoimmune indications",
    ],
    distinguishFrom: [
      "IL-1 — also pyrogenic and pro-inflammatory; anakinra blocks IL-1 receptor",
      "IL-6 — acute-phase response, hepatocyte stimulation; tocilizumab blocks IL-6 receptor",
      "LT-α (lymphotoxin) — related TNF superfamily member; less emphasized on boards",
      "Corticosteroids — broadly ↓ cytokine transcription including TNF, but not receptor-targeted",
    ],
    pediatrics:
      "Same pyrogen pathway in children; anti-TNF agents used in pediatric IBD and JIA with mandatory latent TB screening and infection monitoring.",
  },
  {
    id: "lymphotoxin-beta",
    name: "Lymphotoxin Beta (LTβ)",
    etymology: "Latin lympha = clear fluid + Greek toxikon = poison + beta = second letter",
    aliases: [
      "lymphotoxin beta",
      "lymphotoxin b",
      "lymphotoxin β",
      "ltb",
      "ltβ",
      "lt beta",
      "lymphotoxin-beta",
      "lymphotoxin b beta",
      "lymphotoxin b(beta)",
      "lymphotoxin b (beta)",
      "lymphotoxin beta receptor ligand",
    ],
    type: "Cytokine",
    source:
      "Activated lymphocytes, especially T cells, B cells, and lymphoid tissue inducer cells",
    receptor:
      "LTβ receptor (LTβR) on stromal, endothelial, and myeloid cells → noncanonical NF-κB signaling",
    function:
      "TNF-superfamily cytokine that helps organize secondary lymphoid tissue architecture, high endothelial venules, follicular dendritic cell networks, and lymphoid chemokine expression.",
    clinicalRelevance: [
      "Required for normal lymph node, Peyer patch, and splenic white pulp organization",
      "LTβR signaling supports ectopic lymphoid follicles in chronic inflammation and autoimmunity",
      "Links lymphocytes to stromal cells during lymphoid organ development",
    ],
    boardsPearls: [
      "LTβ is membrane-bound and commonly pairs with LTα as LTα1β2 to signal through LTβR",
      "LTβR → noncanonical NF-κB (NIK/RelB/p52) → lymphoid organogenesis and chemokines",
      "Different from TNF-α: both are TNF-family cytokines, but LTβ is more about lymphoid architecture than fever/septic shock",
      "Peyer patches and organized follicles require lymphotoxin signaling — useful immunology association",
    ],
    distinguishFrom: [
      "TNF-α — soluble/systemic inflammation, fever, cachexia, septic shock",
      "LT-α — related lymphotoxin subunit that can signal through TNF receptors",
      "IL-7 — lymphocyte survival/development cytokine, not lymphoid stromal organization signal",
    ],
    pediatrics:
      "Defective lymphoid organogenesis in development would impair organized mucosal and nodal immune responses; Step 1 usually tests conceptually through Peyer patches/secondary lymphoid tissue.",
  },
  {
    id: "pdgf",
    name: "Platelet-derived growth factor (PDGF)",
    etymology: "platelet = small plate cell fragment + derived = drawn from + growth factor = growth signal",
    aliases: [
      "platelet-derived growth factor",
      "platelet derived growth factor",
      "pdgf",
    ],
    type: "Growth factor",
    source: "Platelets, macrophages, endothelial cells, smooth muscle cells",
    receptor: "Receptor tyrosine kinase (PDGFR-α/β)",
    function:
      "Chemotactic and mitogenic for fibroblasts and smooth muscle cells; key mediator of wound healing and vascular remodeling.",
    clinicalRelevance: [
      "Atherosclerosis: PDGF drives smooth muscle migration and intimal proliferation",
      "Glioblastoma can overexpress PDGF/PDGFR",
      "Imatinib inhibits PDGFR among other tyrosine kinases",
    ],
    boardsPearls: [
      "PDGF released at injury → SMC proliferation in vessel wall",
      "Atherosclerotic plaque: macrophages and SMCs secrete PDGF",
      "Imatinib: BCR-ABL, c-KIT, and PDGFR tyrosine kinase inhibitor",
    ],
    distinguishFrom: [
      "EGF — epithelial proliferation",
      "VEGF — angiogenesis, endothelial growth",
      "TGF-β — fibrosis and extracellular matrix deposition",
    ],
    pediatrics:
      "Wound healing same PDGF pathway; PDGF-receptor mutations rare in juvenile myelomonocytic leukemia context.",
  },
  {
    id: "acetylcholine",
    name: "Acetylcholine (ACh)",
    etymology: "acetyl = CH3CO group + Greek chole = bile + -ine = substance suffix",
    aliases: [
      "acetylcholine",
      "ach",
    ],
    type: "Neurotransmitter",
    source:
      "Cholinergic neurons (CNS), preganglionic sympathetic/parasympathetic fibers, postganglionic parasympathetic fibers, neuromuscular junction (motor end plate)",
    receptor: "Nicotinic (Nm at NMJ; Nn in autonomic ganglia) and muscarinic (M1–M5)",
    function:
      "Primary neurotransmitter of the parasympathetic nervous system; mediates neuromuscular transmission, autonomic ganglia signaling, and cognitive/arousal effects in the CNS.",
    clinicalRelevance: [
      "Myasthenia gravis — autoantibodies to nicotinic ACh receptors at NMJ",
      "Organophosphate poisoning — AChE inhibition → ↑ synaptic ACh → SLUDGE + nicotinic effects",
      "Atropine blocks muscarinic ACh receptors; neuromuscular blockers act at nicotinic NMJ receptors",
    ],
    boardsPearls: [
      "Nicotinic = ion channel (depolarization); muscarinic = GPCR (M3 → IP3/DAG, M2 → ↓ cAMP)",
      "ACh at NMJ: released from motor neuron → binds Nm receptor → muscle contraction",
      "Botulinum toxin ↓ ACh release; organophosphates ↑ ACh (inhibit AChE)",
    ],
    distinguishFrom: [
      "Dopamine, norepinephrine — catecholamine neurotransmitters, not cholinergic",
      "Acetylcholinesterase — enzyme that degrades ACh, not the transmitter itself",
    ],
    pediatrics:
      "Neonatal myasthenia gravis from transplacental anti-AChR antibodies — hypotonia, poor feeding, respiratory weakness.",
  },
  {
    id: "histamine",
    name: "Histamine",
    etymology: "Greek histos = tissue + amine = nitrogen group",
    aliases: ["histamine"],
    type: "Neurotransmitter",
    source:
      "Mast cells, basophils (immune degranulation); histaminergic neurons in hypothalamus; enterochromaffin-like cells in gastric mucosa",
    receptor: "H1 (Gq — vasodilation, bronchoconstriction, pruritus); H2 (Gs — ↑ gastric acid); H3 (CNS presynaptic inhibition)",
    function:
      "Biogenic amine mediator of type I hypersensitivity, gastric acid secretion, vascular permeability, and CNS arousal; stored in mast cell/basophil granules and released upon IgE cross-linking.",
    clinicalRelevance: [
      "Anaphylaxis and allergic rhinitis — histamine causes vasodilation, edema, bronchospasm, urticaria",
      "H1 antihistamines (diphenhydramine, cetirizine) — allergy, pruritus, motion sickness",
      "H2 blockers (famotidine, ranitidine) — peptic ulcer disease, GERD",
      "Carcinoid syndrome — flushing from histamine/serotonin release (H1/H2 blockers help flushing)",
      "Vancomycin red man syndrome — histamine release from rapid infusion (not true IgE allergy)",
    ],
    boardsPearls: [
      "Histamine from mast cell degranulation — type I hypersensitivity effector molecule",
      "H1 → itch, bronchoconstriction, vasodilation; H2 → gastric parietal cell acid secretion",
      "First-generation H1 blockers cross BBB → sedation; second-generation less sedating",
      "Epinephrine treats anaphylaxis; antihistamines are adjunct only",
    ],
    distinguishFrom: [
      "Leukotrienes — also from mast cells; slower, prolonged bronchoconstriction in asthma (late phase)",
      "Serotonin — separate biogenic amine; carcinoid, mood, platelet aggregation",
      "Prostaglandins — arachidonic acid derived; not stored in preformed granules like histamine",
    ],
    pediatrics:
      "Food-induced anaphylaxis — histamine and other mediators from mast cell degranulation; epinephrine IM is first-line in children.",
  },
  {
    id: "nitric-oxide",
    name: "Nitric oxide (NO)",
    etymology: "nitric = nitrogen-derived + oxide = oxygen compound",
    aliases: [
      "nitric oxide",
      "endothelium-derived relaxing factor",
      "edrf",
    ],
    type: "Gasotransmitter",
    source:
      "Endothelial cells (eNOS), macrophages (iNOS), neurons (nNOS); synthesized from L-arginine by nitric oxide synthase (NOS)",
    receptor: "Soluble guanylyl cyclase (intracellular; not a membrane receptor)",
    function:
      "Diffuses into vascular smooth muscle → activates guanylyl cyclase → ↑ cGMP → smooth muscle relaxation and vasodilation.",
    clinicalRelevance: [
      "Nitrates (nitroglycerin) → donate NO → vasodilation in angina",
      "Sildenafil ↑ cGMP by inhibiting PDE-5 — contraindicated with nitrates (severe hypotension)",
      "Pulmonary hypertension treated with NO inhalation or PDE-5 inhibitors",
    ],
    boardsPearls: [
      "NO → guanylyl cyclase → cGMP → vasodilation (opposite of endothelin pathway)",
      "Nitrates + PDE-5 inhibitors = absolute contraindication",
      "NOS requires O₂, NADPH, and arginine — inhibited by asymmetric dimethylarginine (ADMA)",
    ],
    distinguishFrom: [
      "Nitrous oxide (N₂O) — inhaled anesthetic, not the endogenous vasodilator NO",
      "Nitroglycerin — prodrug that releases NO; not the same as endogenous NO signaling molecule",
    ],
    pediatrics:
      "Inhaled NO for persistent pulmonary hypertension of the newborn (PPHN) — selective pulmonary vasodilation.",
  },
  {
    id: "cgmp",
    name: "Cyclic GMP (cGMP)",
    etymology: "cyclic = ring-shaped + guanosine = guanine nucleoside + monophosphate = one phosphate",
    aliases: [
      "cgmp",
      "cyclic gmp",
      "cyclic guanosine monophosphate",
      "3',5'-cyclic gmp",
    ],
    type: "Second messenger",
    source:
      "Synthesized from GTP by guanylyl cyclase (soluble, activated by NO; or natriuretic peptide receptor–linked membrane form)",
    receptor: "Protein kinase G (PKG), cGMP-gated ion channels, phosphodiesterases",
    function:
      "Second messenger mediating vasodilation, natriuresis, and smooth muscle relaxation; degraded by phosphodiesterases (PDE-5 in vascular smooth muscle).",
    clinicalRelevance: [
      "↑ cGMP → vascular smooth muscle relaxation (NO and natriuretic peptide pathways)",
      "PDE-5 inhibitors (sildenafil) block cGMP degradation → prolonged vasodilation",
      "Natriuretic peptides (ANP/BNP) activate membrane guanylyl cyclase → ↑ cGMP → natriuresis",
    ],
    boardsPearls: [
      "NO → ↑ cGMP; PDE-5 breaks down cGMP — sildenafil inhibits PDE-5",
      "cGMP vs cAMP: cAMP from adenylyl cyclase (β-receptors, glucagon); cGMP from guanylyl cyclase (NO, ANP/BNP)",
      "Blue-tinged vision with sildenafil — PDE-6 (retina) also degraded when PDE-5 inhibited",
    ],
    distinguishFrom: [
      "cAMP — adenylyl cyclase second messenger (β-adrenergic, glucagon, PTH)",
      "GTP — substrate for cGMP synthesis, not the active second messenger",
    ],
    pediatrics:
      "Same NO–cGMP pathway in PPHN; sildenafil approved for pediatric PAH (weight-based dosing).",
  },
  {
    id: "prostaglandin",
    name: "Prostaglandins",
    etymology: "Greek prostates = standing before/prostate + gland = secreting organ",
    aliases: [
      "prostaglandin",
      "prostaglandins",
      "pge2",
      "prostaglandin e2",
      "prostaglandin e1",
      "pge1",
      "prostaglandin i2",
      "pgi2",
      "prostacyclin",
    ],
    type: "Hormone",
    source:
      "Synthesized from arachidonic acid via COX pathway in most tissues; PGE₂ widespread, PGI₂ (prostacyclin) from endothelium, PGF₂α from uterus",
    receptor: "GPCRs (EP, IP, FP subtypes) — tissue-specific effects",
    function:
      "Local autacoids mediating inflammation, fever, pain sensitization, gastric mucosal protection, renal afferent vasodilation, uterine contraction, and ductus arteriosus patency (PGE).",
    clinicalRelevance: [
      "NSAIDs ↓ prostaglandins → analgesia/antipyresis but also GI ulcers and ↓ renal perfusion",
      "PGE₁ (alprostadil) keeps ductus arteriosus open in ductal-dependent congenital heart disease",
      "PGE₂ mediates fever via hypothalamic thermoregulation",
      "PGI₂ (prostacyclin) opposes thromboxane — vasodilation and inhibits platelet aggregation",
    ],
    boardsPearls: [
      "COX converts arachidonic acid → PGH₂ → tissue-specific prostaglandins",
      "PGE₂: gastric mucosal protection, renal afferent dilation — lost with NSAIDs",
      "Prostaglandin E1 opens ductus in cyanotic CHD; indomethacin closes PDA in premies",
      "PGI₂ vs thromboxane A₂ — opposing effects on platelets and vessels",
    ],
    distinguishFrom: [
      "Leukotrienes — lipoxygenase pathway, bronchoconstriction in asthma",
      "Thromboxane A₂ — platelet aggregation and vasoconstriction, not general mucosal protection",
      "Histamine — separate mediator in allergy, not arachidonic acid derived",
    ],
    pediatrics:
      "Prostaglandin E1 infusion critical for ductal-dependent lesions (e.g., hypoplastic left heart, interrupted aortic arch) until surgery; monitor for apnea and fever.",
  },
  {
    id: "leukotriene",
    name: "Leukotrienes",
    etymology: "Greek leukos = white cell + tri- = three + -ene = double-bond hydrocarbon",
    aliases: [
      "leukotriene",
      "leukotrienes",
      "ltb4",
      "ltb₄",
      "leukotriene b4",
      "leukotriene b₄",
      "ltc4",
      "ltd4",
      "lte4",
      "cysteinyl leukotrienes",
      "slow-reacting substance of anaphylaxis",
      "srs-a",
    ],
    type: "Hormone",
    source:
      "Synthesized from arachidonic acid via 5-lipoxygenase pathway in mast cells, eosinophils, basophils, and macrophages; not stored preformed (synthesized on demand after PLA₂ activation)",
    receptor:
      "LTB₄ — BLT1/BLT2 (chemotaxis); LTC₄/LTD₄/LTE₄ (cysteinyl leukotrienes) — CysLT1/CysLT2 (bronchoconstriction, vascular permeability)",
    function:
      "Eicosanoid mediators of inflammation: LTB₄ is a potent neutrophil chemoattractant; cysteinyl leukotrienes (LTC₄, LTD₄, LTE₄) cause bronchoconstriction, increased vascular permeability, and mucus secretion.",
    clinicalRelevance: [
      "Asthma late-phase response — cysteinyl leukotrienes cause prolonged bronchoconstriction after allergen exposure",
      "Aspirin-exacerbated respiratory disease — shunting to leukotriene pathway when COX blocked",
      "Montelukast and zafirlukast — CysLT1 receptor antagonists for asthma and allergic rhinitis",
      "Zileuton — 5-lipoxygenase inhibitor ↓ leukotriene synthesis",
      "Anaphylaxis — leukotrienes contribute alongside histamine to bronchospasm and edema",
    ],
    boardsPearls: [
      "Lipoxygenase pathway: arachidonic acid → 5-LOX → leukotrienes (not COX/prostaglandins)",
      "Cysteinyl leukotrienes (LTC₄/D₄/E₄) — slow-reacting substance of anaphylaxis (SRS-A); potent bronchoconstrictors",
      "LTB₄ — major neutrophil chemoattractant linking to chemotaxis",
      "Leukotriene modifiers (montelukast) for mild asthma or aspirin-exacerbated respiratory disease",
      "Corticosteroids ↓ phospholipase A₂ upstream — ↓ leukotriene production",
    ],
    distinguishFrom: [
      "Histamine — preformed mast cell mediator; faster onset, H1/H2 receptors",
      "Prostaglandins — COX pathway from arachidonic acid; PGE₂ causes fever and gastric protection",
      "Thromboxane A₂ — COX pathway in platelets; aggregation and vasoconstriction",
      "Chemokines (IL-8) — peptide chemoattractants, not lipoxygenase eicosanoids",
    ],
    pediatrics:
      "Montelukast approved for pediatric asthma and allergic rhinitis; same CysLT1 mechanism as in adults.",
  },
  {
    id: "thromboxane-a2",
    name: "Thromboxane A₂",
    etymology: "Greek thrombos = clot + oxane = oxygen ring + A2 = second A-series compound",
    aliases: [
      "thromboxane a2",
      "thromboxane a₂",
      "thromboxane",
      "thromboxane 2",
      "txa2",
      "txa₂",
    ],
    type: "Hormone",
    source:
      "Synthesized in platelets from PGH₂ by thromboxane synthase; short half-life (seconds)",
    receptor: "TP receptor (GPCR) on platelets and vascular smooth muscle",
    function:
      "Potent platelet activator and vasoconstrictor; promotes aggregation, granule release, and local thrombus formation.",
    clinicalRelevance: [
      "Aspirin irreversibly inhibits platelet COX-1 → ↓ thromboxane A₂ → antiplatelet effect",
      "Balance with prostacyclin (PGI₂) from endothelium — aspirin affects platelet TXA₂ more than endothelial PGI₂ at low doses",
      "↑ thromboxane activity contributes to arterial thrombosis in ACS",
    ],
    boardsPearls: [
      "Thromboxane A₂: platelet aggregation + vasoconstriction — key target of aspirin",
      "Aspirin ↓ TXA₂ synthesis in platelets (no nucleus → effect lasts platelet lifespan)",
      "NSAIDs reversibly inhibit COX — platelet function recovers as drug clears",
      "PGI₂ (prostacyclin) from endothelium opposes TXA₂ — vasodilation, anti-aggregation",
    ],
    distinguishFrom: [
      "Prostacyclin (PGI₂) — endothelial, vasodilates and inhibits platelets",
      "ADP — separate platelet activation pathway (P2Y12 inhibitors: clopidogrel)",
      "Thrombin — coagulation cascade protease, not eicosanoid",
    ],
    pediatrics:
      "Same aspirin/COX-1 mechanism in children; Reye syndrome risk with aspirin in viral illness — use alternatives for fever in pediatrics.",
  },
  {
    id: "oxytocin",
    name: "Oxytocin",
    etymology: "Greek oxys = swift + tokos = birth",
    aliases: ["oxytocin", "pitocin"],
    type: "Peptide hormone",
    source:
      "Synthesized in hypothalamic paraventricular and supraoptic nuclei; stored and released from posterior pituitary (neurohypophysis)",
    receptor: "Oxytocin receptor (OTR; Gq-coupled GPCR) on myometrium and mammary myoepithelial cells",
    function:
      "Stimulates uterine smooth muscle contraction during labor; triggers milk ejection (let-down reflex) by contracting myoepithelial cells around alveoli.",
    clinicalRelevance: [
      "Exogenous oxytocin (Pitocin) for labor induction and augmentation",
      "Milk ejection reflex — suckling afferents → posterior pituitary oxytocin release",
      "Uterine atony postpartum — oxytocin first-line to reduce hemorrhage",
      "May modulate social bonding and uterine involution (secondary boards context)",
    ],
    boardsPearls: [
      "Posterior pituitary hormones: oxytocin + ADH (vasopressin) — both made in hypothalamus",
      "Oxytocin → uterine contraction + milk ejection; ADH → water reabsorption",
      "Pitocin augments labor; monitor for uterine tachysystole and fetal distress",
      "Suckling triggers oxytocin — prolactin drives milk production (anterior pituitary)",
    ],
    distinguishFrom: [
      "ADH (vasopressin) — water retention via V2 receptors; diabetes insipidus when deficient",
      "Prolactin — anterior pituitary; milk synthesis, not ejection",
      "Prostaglandin F₂α — also uterotonic; used for cervical ripening and abortion",
    ],
    pediatrics:
      "Neonatal breastfeeding establishes suckling reflex → maternal oxytocin release; preterm infants may need lactation support but same hormonal axis.",
  },
  {
    id: "vasopressin",
    name: "Vasopressin",
    etymology: "Latin vas = vessel + pressus = pressed + -in = protein suffix",
    aliases: [
      "vasopressin",
      "antidiuretic hormone",
      "adh",
      "arginine vasopressin",
      "avp",
    ],
    type: "Peptide hormone",
    source:
      "Synthesized in hypothalamic supraoptic and paraventricular nuclei; stored and released from posterior pituitary",
    receptor:
      "V2 receptors (collecting duct; Gs → cAMP → aquaporin-2 insertion); V1 receptors (vascular smooth muscle vasoconstriction)",
    function:
      "Promotes free water reabsorption in renal collecting duct via aquaporin-2; at high levels causes vasoconstriction through V1 receptors.",
    clinicalRelevance: [
      "Central diabetes insipidus — deficient ADH → dilute polyuria and hypernatremia",
      "SIADH — inappropriate ADH → euvolemic hyponatremia with concentrated urine",
      "Desmopressin (DDAVP) — V2-selective analog for central DI and bleeding disorders",
      "Vasopressin infusion used in vasodilatory/septic shock (V1 effect)",
    ],
    boardsPearls: [
      "Posterior pituitary hormones: ADH + oxytocin — both made in hypothalamus",
      "DI: high serum osm + low urine osm; SIADH: low serum osm + inappropriately concentrated urine",
      "Desmopressin treats central DI; nephrogenic DI does not respond (collecting duct defect)",
      "Ethanol inhibits ADH — beer potomania/hyponatremia context",
    ],
    distinguishFrom: [
      "Oxytocin — uterine contraction and milk ejection, not primary water retention hormone",
      "Aldosterone — Na⁺ retention in distal nephron; ADH reabsorbs free water",
      "ANP/BNP — promote natriuresis; oppose volume retention",
    ],
    pediatrics:
      "Central DI in children may follow head trauma or craniopharyngioma; desmopressin is main therapy. SIADH occurs with CNS infection, pulmonary disease, and postoperative states.",
  },
  {
    id: "gnrh",
    name: "GnRH",
    etymology: "GnRH = gonadotropin-releasing hormone",
    aliases: [
      "gnrh",
      "gonadotropin-releasing hormone",
      "gonadotropin releasing hormone",
      "gonadotropin-releasing hormones",
      "lhrh",
      "luteinizing hormone-releasing hormone",
      "luteinizing hormone releasing hormone",
      "gonadorelin",
    ],
    type: "Peptide hormone",
    source:
      "Hypothalamic arcuate and preoptic neurons; released in pulsatile fashion into hypophyseal portal circulation → anterior pituitary",
    receptor:
      "GnRH receptor (GnRHR; Gq-coupled GPCR) on anterior pituitary gonadotrophs",
    function:
      "Stimulates synthesis and pulsatile release of LH and FSH from anterior pituitary → drives gonadal steroidogenesis, gametogenesis, and pubertal development; pulsatile pattern is required for normal gonadotropin secretion.",
    clinicalRelevance: [
      "Hypogonadotropic hypogonadism — deficient GnRH pulsatility (Kallmann syndrome, functional hypothalamic amenorrhea)",
      "Hyperprolactinemia — ↑ prolactin inhibits GnRH pulsatility → ↓ LH/FSH → hypogonadism",
      "Menopause — loss of ovarian estrogen removes negative feedback → ↑ FSH/LH despite intact GnRH",
      "GnRH agonists (leuprolide, goserelin) — continuous exposure → receptor downregulation → ↓ sex steroids (prostate cancer, endometriosis, precocious puberty)",
      "GnRH antagonists (ganirelix, degarelix) — immediate ↓ LH/FSH (IVF, prostate cancer)",
      "Central precocious puberty — premature activation of GnRH pulse generator; treat with GnRH agonists",
    ],
    boardsPearls: [
      "GnRH is pulsatile — continuous GnRH (agonist therapy) paradoxically suppresses gonadotropins",
      "Hypothalamus → GnRH → anterior pituitary LH/FSH → gonadal estrogen/testosterone",
      "Kallmann syndrome — ↓ GnRH neuron migration + anosmia + delayed puberty",
      "Prolactinoma inhibits GnRH → galactorrhea + amenorrhea/infertility",
      "vs CRH/TRH/GHRH — other hypothalamic releasing hormones with distinct pituitary targets",
      "Pulsatile GnRH pump — treats hypogonadotropic hypogonadism; continuous agonist suppresses axis",
    ],
    distinguishFrom: [
      "LH / FSH — anterior pituitary gonadotropins downstream of GnRH, not hypothalamic releasing hormone",
      "GnRH agonist drugs — pharmacologic continuous stimulation causing downregulation, not physiologic pulses",
      "hCG — mimics LH action at ovary/testis; does not act on pituitary GnRH receptor",
      "Prolactin — inhibits GnRH release; does not stimulate gonadotropins",
    ],
    pediatrics:
      "Central precocious puberty — GnRH agonists suppress premature pubertal progression; Kallmann presents with delayed puberty and anosmia from failed GnRH neuron migration.",
  },
  {
    id: "estrogen",
    name: "Estrogen",
    etymology: "Greek oistros = frenzy/estrus + -gen = producing",
    aliases: [
      "estrogen",
      "estrogens",
      "estradiol",
      "estradiol-17β",
      "e2",
      "17β-estradiol",
      "estrone",
      "e1",
      "estriol",
      "e3",
      "ethinyl estradiol",
    ],
    type: "Hormone",
    source:
      "Ovarian granulosa cells (estradiol from theca-androgen aromatization); placenta in pregnancy; adipose aromatization; small amounts from testes/adrenals",
    receptor:
      "Intracellular/nuclear estrogen receptors (ERα, ERβ) — ligand-activated transcription factors; membrane ER signaling also exists",
    function:
      "Promotes female secondary sex characteristics, endometrial proliferation, breast ductal development, epiphyseal closure, and negative feedback on FSH/LH; maintains bone density and cardiovascular effects.",
    clinicalRelevance: [
      "Estrogen deficiency — menopause, Turner syndrome, primary ovarian insufficiency → hot flashes, osteoporosis, ↑ CV risk",
      "Estrogen excess or unopposed estrogen — endometrial hyperplasia/cancer risk",
      "Tamoxifen — SERM with antagonist effect in breast, partial agonist in endometrium",
      "Aromatase inhibitors (anastrozole) — block peripheral/ tumor estrogen synthesis in ER+ breast cancer",
      "OCPs — ethinyl estradiol + progestin for contraception and cycle regulation",
    ],
    boardsPearls: [
      "Estradiol (E2) — most potent endogenous estrogen; drives endometrial proliferation in follicular phase",
      "Estrone (E1) dominant after menopause; estriol (E3) from placenta in pregnancy",
      "Unopposed estrogen ↑ endometrial cancer risk — progesterone/progestin opposes proliferation",
      "Turner: streak gonads → ↓ estrogen → webbed neck, short stature, primary amenorrhea",
      "Aromatase converts androgens → estrogens — inhibitors used in postmenopausal breast cancer",
      "Follicular phase: estrogen ↑ → LH surge → ovulation; luteal phase dominated by progesterone",
    ],
    distinguishFrom: [
      "Progesterone — stabilizes endometrium, secretory phase; opposes estrogen-driven proliferation",
      "Prolactin — milk synthesis; high prolactin suppresses GnRH → ↓ estrogen",
      "Testosterone — androgen; aromatized to estrogen peripherally",
    ],
    pediatrics:
      "Precocious puberty — early estrogen exposure → breast development, accelerated bone age; McCune-Albright or ovarian tumor workup.",
  },
  {
    id: "progesterone",
    name: "Progesterone",
    etymology: "pro- = supporting + gestare = carry pregnancy + -one = ketone hormone suffix",
    aliases: [
      "progesterone",
      "progestin",
      "progestins",
      "progestogen",
      "progestogens",
      "progestational hormone",
      "corpus luteum hormone",
      "medroxyprogesterone",
      "norethindrone",
      "levonorgestrel",
    ],
    type: "Hormone",
    source:
      "Corpus luteum after ovulation (LH-stimulated granulosa/theca-lutein cells); placenta (syncytiotrophoblast) in pregnancy; small adrenal contribution",
    receptor:
      "Progesterone receptor (PR) — intracellular/nuclear ligand-activated transcription factor; progestins are synthetic PR agonists",
    function:
      "Transforms endometrium from proliferative to secretory phase; stabilizes endometrium for implantation; maintains early pregnancy; raises basal body temperature; supports breast alveolar development; provides negative feedback on GnRH/LH; relaxes smooth muscle (GI, ureter) in pregnancy.",
    clinicalRelevance: [
      "Luteal phase — progesterone from corpus luteum; withdrawal if no implantation → menstruation",
      "Corpus luteum of pregnancy — progesterone maintains uterine quiescence until placental takeover (~8–10 weeks)",
      "Unopposed estrogen without progesterone — endometrial hyperplasia and cancer risk",
      "OCPs and progestin-only pills/IUDs — progestins prevent ovulation and/or thicken cervical mucus",
      "Mifepristone — progesterone receptor antagonist used for medical abortion",
      "Luteal phase defect / low progesterone — infertility and recurrent pregnancy loss (controversial supplementation)",
      "17-hydroxyprogesterone — elevated in 21-hydroxylase CAH (steroid precursor, not therapeutic progesterone)",
    ],
    boardsPearls: [
      "Estrogen proliferates endometrium; progesterone stabilizes/secretory — unopposed estrogen is carcinogenic",
      "Progesterone withdrawal bleeding — drop in progesterone triggers menses",
      "↑ basal body temperature in luteal phase — progesterone thermogenic effect",
      "HRT with uterus: estrogen + progestin; estrogen alone only if hysterectomy",
      "Mifepristone blocks PR → decidual breakdown + prostaglandin sensitization (with misoprostol)",
      "vs aldosterone — mineralocorticoid; progesterone has weak anti-mineralocorticoid activity at high doses",
    ],
    distinguishFrom: [
      "Estrogen — proliferative phase hormone; drives endometrial growth; aromatized from androgens",
      "hCG — maintains corpus luteum early in pregnancy; not the same as progesterone itself",
      "Prolactin — lactation hormone; high levels suppress GnRH, not a progestational steroid",
      "17-hydroxyprogesterone — CAH screening analyte; precursor steroid, not functional luteal progesterone",
    ],
    pediatrics:
      "Adolescent anovulatory cycles may lack robust luteal progesterone → irregular menses; congenital absence of progesterone effect is not a typical isolated pediatric presentation — CAH presents with androgen excess from steroid pathway blocks.",
  },
  {
    id: "androgen",
    name: "Androgens",
    etymology: "Greek aner/andros = male + -gen = producing",
    aliases: [
      "androgen",
      "androgens",
      "testosterone",
      "dihydrotestosterone",
      "dht",
      "androstenedione",
      "dhea",
      "dehydroepiandrosterone",
    ],
    type: "Hormone",
    source:
      "Testicular Leydig cells (testosterone, stimulated by LH); ovarian theca cells and adrenal zona reticularis (androstenedione, DHEA); peripheral 5α-reductase converts testosterone → DHT in prostate, skin, external genitalia",
    receptor:
      "Androgen receptor (AR) — intracellular/nuclear ligand-activated transcription factor; DHT binds AR with higher affinity than testosterone",
    function:
      "Promote male internal (Wolffian duct) and external genital development, secondary sex characteristics, libido, muscle mass, erythropoiesis, sebum production, and prostate growth; in females, converted to estrogen via aromatase and contribute to pubic/axillary hair.",
    clinicalRelevance: [
      "Congenital adrenal hyperplasia (21-hydroxylase deficiency) — shunting to androgen pathway → virilization",
      "PCOS — ↑ ovarian and adrenal androgens → hirsutism, acne, anovulation",
      "5α-reductase deficiency — ↓ DHT → ambiguous external genitalia in 46,XY males; Wolffian structures normal (testosterone intact)",
      "Androgen insensitivity syndrome (46,XY, defective AR) — female external phenotype, no uterus, blind vagina",
      "Finasteride — 5α-reductase inhibitor ↓ DHT for BPH and androgenetic alopecia",
      "Spironolactone, flutamide, bicalutamide — antiandrogen effects",
      "GnRH agonists or orchiectomy ↓ androgens in prostate cancer",
    ],
    boardsPearls: [
      "Testosterone from Leydig cells (LH-driven); DHT via 5α-reductase — required for prostate and external male genitalia",
      "5α-reductase deficiency: internal male genitalia present, ambiguous external genitalia at birth; virilizes at puberty",
      "Androgen insensitivity: 46,XY female phenotype, ↑ testosterone and LH, absent uterus",
      "CAH 21-hydroxylase — ↑ 17-OHP and androgens → virilized female infant",
      "Aromatase converts androgens → estrogens; finasteride blocks testosterone → DHT conversion",
      "BPH is androgen (DHT) dependent — 5α-reductase inhibitors shrink prostate",
    ],
    distinguishFrom: [
      "Estrogen — feminizing steroids; aromatized from androgens in ovary and adipose",
      "Progesterone — progestational hormone; not primarily androgenic",
      "Anabolic steroids — synthetic androgen analogs with ↑ anabolic:androgenic ratio abuse",
      "Corticosteroids — glucocorticoid/mineralocorticoid activity, not gonadal androgens",
    ],
    pediatrics:
      "CAH virilized female newborn — ↑ androgens from 21-hydroxylase deficiency; 5α-reductase deficiency presents with ambiguous genitalia in 46,XY infants who virilize at puberty.",
  },
  {
    id: "calcitonin",
    name: "Calcitonin",
    etymology: "Latin calx = calcium + Greek tonos = tension/regulation + -in = peptide",
    aliases: ["calcitonin", "thyrocalcitonin"],
    type: "Peptide hormone",
    source: "Parafollicular C cells of thyroid",
    receptor: "Calcitonin receptor (Gs-coupled) on osteoclasts and kidney",
    function:
      "Lowers serum calcium by inhibiting osteoclast-mediated bone resorption; minor physiologic role in adult calcium homeostasis.",
    clinicalRelevance: [
      "Tumor marker for medullary thyroid carcinoma",
      "Elevated in MEN2-associated C-cell tumors",
      "Salmon calcitonin can treat hypercalcemia/Paget disease but is less common now",
    ],
    boardsPearls: [
      "Medullary thyroid carcinoma from parafollicular C cells secretes calcitonin",
      "MEN2A/2B: RET mutation + medullary thyroid carcinoma",
      "PTH and vitamin D dominate calcium regulation; calcitonin is a board tumor marker",
    ],
    distinguishFrom: [
      "PTH — raises calcium; from parathyroid chief cells",
      "Calcitriol — active vitamin D; increases intestinal calcium absorption",
      "Thyroglobulin — follicular thyroid marker, not C-cell marker",
    ],
  },
  {
    id: "bradykinin",
    name: "Bradykinin",
    etymology: "Greek bradys = slow + kinein = to move",
    aliases: ["bradykinin", "bradykin", "kinin"],
    type: "Peptide hormone",
    source: "Kallikrein cleavage of high-molecular-weight kininogen",
    receptor: "B2 receptor (constitutive) and B1 receptor (inflammation)",
    function:
      "Vasoactive peptide causing vasodilation, increased vascular permeability, pain, and bronchoconstriction.",
    clinicalRelevance: [
      "ACE degrades bradykinin; ACE inhibitors increase bradykinin → cough/angioedema",
      "C1 esterase inhibitor deficiency → excess bradykinin → hereditary angioedema",
      "Contributes to pain and swelling in inflammation",
    ],
    boardsPearls: [
      "ACE = kininase II; ACE inhibitors raise bradykinin",
      "Hereditary angioedema is bradykinin-mediated, not histamine-mediated",
      "No urticaria in classic bradykinin angioedema",
    ],
    distinguishFrom: [
      "Histamine — mast cell mediator with urticaria/pruritus",
      "Angiotensin II — vasoconstrictor; ACE generates it while degrading bradykinin",
    ],
  },
  {
    id: "il-3",
    name: "Interleukin-3 (IL-3)",
    etymology: "interleukin = between leukocytes + 3 = cytokine number",
    aliases: ["il-3", "il 3", "interleukin-3", "interleukin 3"],
    type: "Cytokine",
    source: "Activated T cells and mast cells",
    receptor: "IL-3 receptor (JAK-STAT)",
    function:
      "Stimulates proliferation and differentiation of early hematopoietic progenitors, especially myeloid lineages.",
    mnemonic:
      "IL-3 = three marrow lines: broad early hematopoietic progenitor support.",
    clinicalRelevance: [
      "Links T-cell activation to marrow myelopoiesis",
      "Less clinically tested than IL-5/G-CSF but high-yield as hematopoietic growth signal",
    ],
    boardsPearls: [
      "IL-3 supports bone marrow progenitor growth",
      "Contrast with GM-CSF (granulocyte/macrophage) and IL-5 (eosinophils)",
    ],
  },
  {
    id: "il-10",
    name: "Interleukin-10 (IL-10)",
    etymology: "interleukin = between leukocytes + 10 = cytokine number",
    aliases: ["il-10", "il 10", "interleukin-10", "interleukin 10"],
    type: "Cytokine",
    source: "Treg cells, Th2 cells, macrophages, dendritic cells",
    receptor: "IL-10 receptor (JAK-STAT)",
    function:
      "Anti-inflammatory cytokine that suppresses macrophage and dendritic cell cytokine production and antigen presentation.",
    mnemonic:
      "IL-10 = ten down: turns inflammatory macrophage/Th1 responses down.",
    clinicalRelevance: [
      "Limits Th1/macrophage inflammation",
      "Treg-mediated immune tolerance uses IL-10 and TGF-β",
    ],
    boardsPearls: [
      "IL-10 inhibits macrophages and Th1 responses",
      "Anti-inflammatory pair: IL-10 and TGF-β",
    ],
    distinguishFrom: ["IL-12 — promotes Th1 and IFN-γ", "IFN-γ — activates macrophages"],
  },
  {
    id: "il-11",
    name: "Interleukin-11 (IL-11)",
    etymology: "interleukin = between leukocytes + 11 = cytokine number",
    aliases: ["il-11", "il 11", "interleukin-11", "interleukin 11"],
    type: "Cytokine",
    source: "Bone marrow stromal cells, fibroblasts, epithelial cells, and osteoblast-lineage cells",
    receptor: "IL-11 receptor α + gp130 → JAK-STAT3",
    function:
      "IL-6-family cytokine that supports megakaryocyte maturation and platelet recovery, modulates stromal/epithelial repair, and can drive fibrosis when chronically activated.",
    mnemonic:
      "IL-11 = two ones look like platelet sticks: megakaryocytes/platelets.",
    clinicalRelevance: [
      "Oprelvekin (recombinant IL-11) was used for chemotherapy-associated thrombocytopenia",
      "IL-11/gp130 signaling overlaps with IL-6-family acute-phase and stromal repair pathways",
      "Excess IL-11 signaling has been implicated in fibrotic remodeling",
    ],
    boardsPearls: [
      "IL-11 is the platelet-support cytokine in classic interleukin tables",
      "Thrombopoietin is the main physiologic platelet regulator; IL-11 is the board-style adjunct",
      "gp130 receptor family links IL-11 with IL-6 signaling logic",
    ],
    distinguishFrom: [
      "Thrombopoietin — primary megakaryocyte/platelet growth factor from liver and kidney",
      "IL-3 — broad hematopoietic progenitor growth",
      "GM-CSF — granulocyte/macrophage progenitors, not platelet-focused",
    ],
  },
  {
    id: "il-12",
    name: "Interleukin-12 (IL-12)",
    etymology: "interleukin = between leukocytes + 12 = cytokine number",
    aliases: ["il-12", "il 12", "interleukin-12", "interleukin 12"],
    type: "Cytokine",
    source: "Macrophages and dendritic cells",
    receptor: "IL-12 receptor (JAK-STAT)",
    function:
      "Promotes Th1 differentiation and stimulates NK/T cells to produce IFN-γ, enhancing intracellular pathogen killing.",
    mnemonic:
      "IL-12 = one-two punch: APC tells T/NK cells → IFN-γ → macrophage killing.",
    clinicalRelevance: [
      "IL-12 receptor deficiency → mycobacterial and Salmonella susceptibility",
      "Key bridge from innate APCs to Th1 immunity",
    ],
    boardsPearls: [
      "IL-12 → Th1 → IFN-γ → macrophage activation",
      "Defects in IL-12/IFN-γ axis → disseminated atypical mycobacteria",
    ],
    distinguishFrom: ["IL-10 — inhibits macrophages/Th1", "IL-4 — promotes Th2 and IgE"],
  },
  {
    id: "il-13",
    name: "Interleukin-13 (IL-13)",
    etymology: "interleukin = between leukocytes + 13 = cytokine number",
    aliases: ["il-13", "il 13", "interleukin-13", "interleukin 13"],
    type: "Cytokine",
    source: "Th2 cells, type 2 innate lymphoid cells (ILC2), mast cells, basophils, and eosinophils",
    receptor:
      "IL-13 receptor α1 with IL-4 receptor α (type II IL-4 receptor) → JAK-STAT6",
    function:
      "Type 2 cytokine that increases mucus production, goblet-cell metaplasia, airway hyperreactivity, alternative macrophage activation, tissue remodeling, and IgE-associated allergic inflammation.",
    mnemonic:
      "IL-13 = unlucky airways: mucus + hyperreactivity, like IL-4 but more airway/barrier.",
    clinicalRelevance: [
      "Asthma, allergic rhinitis, atopic dermatitis, and eosinophilic esophagitis involve IL-13/IL-4 type 2 signaling",
      "Dupilumab blocks IL-4Rα shared by IL-4 and IL-13 pathways",
      "IL-13 contributes to fibrosis and mucus plugging in chronic type 2 inflammation",
    ],
    boardsPearls: [
      "Th2 triad: IL-4 = IgE switch; IL-5 = eosinophils; IL-13 = mucus/airway hyperreactivity",
      "IL-13 overlaps with IL-4 because both can signal through IL-4Rα",
      "Alternative macrophage activation and tissue repair/fibrosis are type 2 themes",
    ],
    distinguishFrom: [
      "IL-4 — stronger association with Th2 differentiation and IgE class switching",
      "IL-5 — eosinophil survival/activation",
      "IL-17 — neutrophilic mucosal inflammation, not type 2 mucus/eosinophil pattern",
    ],
    pediatrics:
      "Childhood asthma and atopic dermatitis commonly reflect type 2 inflammation; IL-13/IL-4 blockade is used in selected pediatric atopic disease.",
  },
  {
    id: "il-15",
    name: "Interleukin-15 (IL-15)",
    etymology: "interleukin = between leukocytes + 15 = cytokine number",
    aliases: ["il-15", "il 15", "interleukin-15", "interleukin 15"],
    type: "Cytokine",
    source: "Monocytes, macrophages, dendritic cells, epithelial cells, and stromal cells",
    receptor:
      "IL-15 receptor α presents IL-15 to IL-2/15Rβ (CD122) + common γ chain (CD132) → JAK1/JAK3-STAT5",
    function:
      "Supports NK-cell development, survival, and activation; maintains memory CD8⁺ T cells and promotes cytotoxic lymphocyte function.",
    mnemonic:
      "IL-15 = fifteen natural killers on patrol: NK cells + memory CD8 survival.",
    clinicalRelevance: [
      "Common γ-chain defects impair IL-15 signaling and cause absent NK cells in X-linked SCID",
      "Cancer immunotherapy research uses IL-15 agonists to expand NK and CD8 cytotoxic responses",
      "IL-15 can contribute to inflammatory cytotoxic T-cell activation in autoimmune disease",
    ],
    boardsPearls: [
      "IL-15 is the NK-cell survival/development cytokine",
      "IL-2 and IL-15 share receptor β/γ components but IL-2 expands activated T cells; IL-15 maintains NK/memory CD8 cells",
      "Absent NK cells in common γ-chain SCID reflects failed IL-15 signaling",
    ],
    distinguishFrom: [
      "IL-2 — activated T-cell clonal expansion and Treg support",
      "IL-7 — early T-cell development and lymphoid survival",
      "IL-12 — induces NK/T-cell IFN-γ production, but does not build NK cells",
    ],
    pediatrics:
      "X-linked SCID in infants includes failed IL-15 signaling with absent NK cells; presents with severe viral, fungal, and opportunistic infections.",
  },
  {
    id: "il-17",
    name: "Interleukin-17 (IL-17)",
    etymology: "interleukin = between leukocytes + 17 = cytokine number",
    aliases: [
      "il-17",
      "il 17",
      "interleukin-17",
      "interleukin 17",
      "il-17a",
      "il-17f",
      "th17 cytokine",
    ],
    type: "Cytokine",
    source: "Th17 cells, γδ T cells, innate lymphoid cells, and mucosal lymphocytes",
    receptor: "IL-17RA/IL-17RC receptor complex → Act1/TRAF6 → NF-κB and MAPK",
    function:
      "Th17 effector cytokine that induces epithelial, endothelial, fibroblast, and macrophage release of chemokines (especially IL-8/CXCL8) and G-CSF, recruiting neutrophils and strengthening mucosal defense against extracellular bacteria and fungi.",
    mnemonic:
      "IL-17 = seventeen neutrophils: Th17 calls neutrophils to mucosa.",
    clinicalRelevance: [
      "Chronic mucocutaneous candidiasis with IL-17 pathway defects",
      "Psoriasis and ankylosing spondylitis — IL-17-driven keratinocyte and neutrophilic inflammation",
      "Secukinumab/ixekizumab block IL-17A; brodalumab blocks IL-17 receptor",
      "Th17 defects contribute to recurrent Candida and Staphylococcus infections in hyper-IgE syndrome",
    ],
    boardsPearls: [
      "IL-17 recruits neutrophils indirectly by inducing IL-8/CXCL8 and G-CSF",
      "Th17 differentiation starts with TGF-β + IL-6; IL-23 sustains Th17 cells",
      "Extracellular bacteria/fungi at mucosa = Th17/IL-17 axis",
      "IL-17 is neutrophil-skewed; IL-5 is eosinophil-skewed",
    ],
    distinguishFrom: [
      "IL-8/CXCL8 — direct neutrophil chemokine downstream of IL-17",
      "IL-23 — sustains/expands Th17 cells; upstream of IL-17 production",
      "IL-12 — Th1/IFN-γ axis for intracellular pathogens",
    ],
    pediatrics:
      "Hyper-IgE syndrome presents in childhood with impaired Th17/IL-17 mucosal defense, recurrent staph abscesses, Candida, eczema, and retained primary teeth.",
  },
  {
    id: "il-18",
    name: "Interleukin-18 (IL-18)",
    etymology: "interleukin = between leukocytes + 18 = cytokine number",
    aliases: ["il-18", "il 18", "interleukin-18", "interleukin 18", "ifn-gamma-inducing factor"],
    type: "Cytokine",
    source: "Macrophages, dendritic cells, epithelial cells, and inflammasome-activated innate cells",
    receptor: "IL-18 receptor → MyD88 → NF-κB/MAPK; mature IL-18 generated by caspase-1",
    function:
      "Inflammasome-processed IL-1-family cytokine that synergizes with IL-12 to induce IFN-γ from NK and T cells, amplifying Th1/macrophage responses.",
    mnemonic:
      "IL-18 = eighteen helps twelve: with IL-12, drives IFN-γ.",
    clinicalRelevance: [
      "Inflammasome activation processes IL-1β and IL-18 via caspase-1",
      "High IL-18 is linked to macrophage activation syndrome/HLH and severe systemic inflammation",
      "Contributes to Th1 inflammation and host defense against intracellular pathogens",
    ],
    boardsPearls: [
      "IL-18 belongs with IL-1 family/inflammasome logic, not JAK-STAT common γ-chain cytokines",
      "IL-12 + IL-18 → strong IFN-γ from NK/T cells",
      "Caspase-1 processes pro–IL-1β and pro–IL-18",
    ],
    distinguishFrom: [
      "IL-12 — APC cytokine that independently promotes Th1 differentiation",
      "IL-1β — inflammasome pyrogen/endothelial activation cytokine",
      "IFN-γ — downstream macrophage-activating cytokine induced by IL-12/IL-18",
    ],
    pediatrics:
      "Macrophage activation syndrome and HLH in children can involve very high IL-18 with fever, cytopenias, hepatitis, and hyperferritinemia.",
  },
  {
    id: "il-21",
    name: "Interleukin-21 (IL-21)",
    etymology: "interleukin = between leukocytes + 21 = cytokine number",
    aliases: ["il-21", "il 21", "interleukin-21", "interleukin 21"],
    type: "Cytokine",
    source: "T follicular helper cells, Th17 cells, and activated CD4⁺ T cells",
    receptor: "IL-21 receptor + common γ chain (CD132) → JAK1/JAK3-STAT3",
    function:
      "Tfh-linked cytokine that promotes germinal center B-cell proliferation, plasma-cell differentiation, class switching, CD8⁺ T-cell function, NK-cell activity, and Th17 amplification.",
    mnemonic:
      "IL-21 = blackjack helper: Tfh helps B cells win germinal centers.",
    clinicalRelevance: [
      "Important for antibody responses and Tfh-B cell collaboration",
      "Common γ-chain cytokine; signaling overlaps with IL-2/4/7/9/15 via CD132",
      "Dysregulated IL-21 contributes to autoantibody production in autoimmune disease models",
    ],
    boardsPearls: [
      "IL-21 is the Tfh/B-cell help cytokine",
      "STAT3 pathway links IL-21 to B-cell differentiation and Th17 biology",
      "Contrast IL-4: class switch to IgE; IL-21: broader germinal center/plasma-cell support",
    ],
    distinguishFrom: [
      "IL-4 — Th2 IgE class-switching signal",
      "IL-2 — T-cell proliferation and Treg support",
      "CD40L — required contact-dependent T-cell help for class switching",
    ],
  },
  {
    id: "il-22",
    name: "Interleukin-22 (IL-22)",
    etymology: "interleukin = between leukocytes + 22 = cytokine number",
    aliases: ["il-22", "il 22", "interleukin-22", "interleukin 22"],
    type: "Cytokine",
    source: "Th17 cells, Th22 cells, type 3 innate lymphoid cells, and NK-like cells",
    receptor: "IL-22 receptor (IL-22R1 + IL-10R2) on epithelial/stromal cells → JAK-STAT3",
    function:
      "Barrier cytokine that acts mainly on epithelial cells to induce antimicrobial peptides, mucin, tight-junction support, tissue repair, and acute-phase-like responses at mucosal surfaces.",
    mnemonic:
      "IL-22 = two-two walls: reinforces epithelial barriers on both sides.",
    clinicalRelevance: [
      "Mucosal defense against extracellular bacteria and fungi, especially gut and skin barriers",
      "Can be protective in epithelial repair but pathogenic in psoriasis and chronic inflammation",
      "Works with IL-17 in keratinocytes and mucosal epithelium",
    ],
    boardsPearls: [
      "IL-22 acts on epithelium more than leukocytes — barrier repair and antimicrobial peptides",
      "Th17 output includes IL-17, IL-21, IL-22; IL-17 recruits neutrophils, IL-22 repairs barrier",
      "IL-22 is in the IL-10 cytokine family but is pro-barrier, not broadly anti-inflammatory like IL-10",
    ],
    distinguishFrom: [
      "IL-17 — neutrophil recruitment via chemokines/G-CSF",
      "IL-10 — suppresses macrophages/APCs",
      "IL-13 — type 2 mucus/airway hyperreactivity rather than Th17 barrier defense",
    ],
    pediatrics:
      "Barrier immunity matters in pediatric IBD and recurrent mucocutaneous infections; IL-22 can be protective in epithelial repair but harmful if chronically overactive.",
  },
  {
    id: "il-23",
    name: "Interleukin-23 (IL-23)",
    etymology: "interleukin = between leukocytes + 23 = cytokine number",
    aliases: [
      "il-23",
      "il 23",
      "interleukin-23",
      "interleukin 23",
      "il-23p19",
      "il12b",
      "il-12p40",
    ],
    type: "Cytokine",
    source: "Dendritic cells and macrophages",
    receptor: "IL-23 receptor + IL-12Rβ1 → JAK2/TYK2-STAT3/STAT4",
    function:
      "IL-12-family cytokine that sustains and expands committed Th17 cells, promoting IL-17, IL-21, IL-22, and GM-CSF production for mucosal defense and chronic inflammation.",
    mnemonic:
      "IL-23 = twenty-THRee keeps TH17: maintains Th17, not first differentiation.",
    clinicalRelevance: [
      "Psoriasis, psoriatic arthritis, ankylosing spondylitis, and IBD involve IL-23/Th17 inflammation",
      "Ustekinumab blocks shared IL-12/23 p40; guselkumab/risankizumab/tildrakizumab block IL-23 p19",
      "IL-23 shares p40 subunit and IL-12Rβ1 receptor component with IL-12",
    ],
    boardsPearls: [
      "TGF-β + IL-6 initiates Th17 differentiation; IL-23 maintains/expands Th17",
      "IL-23 → Th17 → IL-17/IL-22 → neutrophils + barrier defense",
      "IL-12 drives Th1/IFN-γ; IL-23 drives Th17/IL-17",
      "Anti-p40 biologics hit both IL-12 and IL-23; anti-p19 is IL-23-selective",
    ],
    distinguishFrom: [
      "IL-12 — p35+p40 cytokine for Th1 and IFN-γ",
      "IL-17 — downstream Th17 effector cytokine",
      "IL-6 — starts Th17 differentiation with TGF-β and drives acute phase response",
    ],
    pediatrics:
      "Pediatric psoriasis and IBD can involve IL-23/Th17 inflammation; IL-12/23 or IL-23 biologics may be used by specialty indication and age.",
  },
  {
    id: "ifn-gamma",
    name: "Interferon-gamma (IFN-γ)",
    etymology: "interferon = interferes with viral replication + gamma = third classic class",
    aliases: ["ifn-gamma", "ifn gamma", "ifn-γ", "interferon-gamma", "interferon gamma"],
    type: "Cytokine",
    source: "Th1 cells, CD8 T cells, NK cells",
    receptor: "IFN-γ receptor (JAK1/JAK2-STAT1)",
    function:
      "Activates macrophages, increases MHC I/II expression, promotes Th1 responses, and supports IgG class switching.",
    clinicalRelevance: [
      "Defective IFN-γ/IL-12 axis → disseminated mycobacterial infection",
      "IGRA TB tests measure IFN-γ release after TB antigen stimulation",
      "Therapeutic IFN-γ can reduce infections in chronic granulomatous disease",
    ],
    boardsPearls: [
      "Th1 signature cytokine = IFN-γ",
      "IFN-γ activates macrophages for intracellular pathogen killing",
      "IL-12 induces IFN-γ; IL-10 suppresses this axis",
    ],
    distinguishFrom: ["Type I interferons (IFN-α/β) — antiviral state", "IL-4 — Th2 cytokine"],
  },
  {
    id: "interferons",
    name: "Interferons",
    etymology: "interfere = block viral replication + -on = substance suffix",
    aliases: ["interferon", "interferons", "ifn", "type i interferon", "ifn-alpha", "ifn-beta"],
    type: "Cytokine",
    source: "Virus-infected cells, plasmacytoid dendritic cells, T cells/NK cells depending on subtype",
    receptor: "IFNAR for type I IFNs; IFNGR for IFN-γ",
    function:
      "Cytokine family that induces antiviral state, increases antigen presentation, and coordinates innate/adaptive immunity.",
    clinicalRelevance: [
      "IFN-α historically used for hepatitis C and melanoma",
      "IFN-β used in multiple sclerosis",
      "IFN-γ is Th1/macrophage activating",
    ],
    boardsPearls: [
      "Type I IFNs (α/β) are antiviral and upregulate MHC I",
      "IFN-γ is type II interferon and activates macrophages",
      "Viral immune evasion often blocks interferon signaling",
    ],
  },
  {
    id: "gm-csf",
    name: "GM-CSF",
    etymology: "GM = granulocyte-macrophage + CSF = colony-stimulating factor",
    aliases: ["gm-csf", "gm csf", "granulocyte macrophage colony stimulating factor", "sargramostim"],
    type: "Growth factor",
    source: "T cells, macrophages, endothelial cells, fibroblasts",
    receptor: "GM-CSF receptor (JAK2-STAT5)",
    function:
      "Stimulates granulocyte and macrophage progenitor proliferation and activation.",
    clinicalRelevance: [
      "Sargramostim can aid marrow recovery after chemotherapy/transplant",
      "Autoantibodies to GM-CSF associated with pulmonary alveolar proteinosis",
    ],
    boardsPearls: [
      "GM-CSF grows granulocyte/macrophage colonies",
      "G-CSF is neutrophil-focused; GM-CSF broader myeloid stimulation",
    ],
  },
];

const signalingById = new Map(
  SIGNALING_MOLECULES.map((entry) => [entry.id, entry]),
);

export function getSignalingById(id: string): SignalingEntry | undefined {
  return signalingById.get(id);
}

export interface SignalingAliasMatch {
  alias: string;
  signalingId: string;
}

export function buildSignalingAliasIndex(): SignalingAliasMatch[] {
  const matches: SignalingAliasMatch[] = [];
  for (const entry of SIGNALING_MOLECULES) {
    for (const alias of entry.aliases) {
      matches.push({ alias: alias.toLowerCase(), signalingId: entry.id });
    }
  }
  return matches.sort((a, b) => b.alias.length - a.alias.length);
}
